IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. It operates through its subsidiaries IBEX Pharmaceuticals Inc. and Bio-Research Products, Inc. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enxymes, cartilage assays, collagen antibodies, aminoethyl-benzenesulfonyl, diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montréal, Canada.